Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

3-Arm Randomized Placebo Controlled Double Blind Phase 3 Study to Evaluate Safety and Efficacy of Once-Daily and Twice-Daily Hydrocortisone Acetate 90 mg Suppository Administered With a Sephure Suppository Applicator in Subjects With Ulcerative Colitis of the Rectum

NCT04469686 is registered in ClinicalTrials.gov with Cristcot HCA LLC as lead sponsor.

NCT NCT04469686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04469686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
3-Arm Randomized Placebo Controlled Double Blind Phase 3 Study to Evaluate Safety and Efficacy of Once-Daily and Twice-Daily Hydrocortisone Acetate 90 mg Suppository Administered With a Sephure Suppository Applicator in Subjects With Ulcerative Colitis of the Rectum
Lead sponsor
Cristcot HCA LLC
Phase
Phase 3
Overall status
Completed
Start date
December 10, 2020
Completion date
September 19, 2024
Enrollment
200 (actual)
Sites
189

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative proctitis